1,516 articles
Peter P. Nawroth
Peter P. Nawroth is a German physician-scientist known for research on diabetic late complications, especially methylglyoxal, who held a Heidelberg chair from 2001 to 2020.
Peter R. Maroko
Peter R. Maroko is a physician-scientist in cardiology known for showing that the size of a myocardial infarction can be reduced by drugs and by restoring blood flow.
Peter Rehling
Peter Rehling (born 1966) is a German biochemist who has led the Institute of Cellular Biochemistry at the University Medical Center Göttingen since 2007, known for work on mitochondrial protein import and respiratory-chain assembly.
Peter Rotwein
Peter Rotwein is an American physician-scientist in endocrinology and biochemistry known for work on insulin-like growth factors and early studies linking insulin-gene variation to type 2 diabetes.
Peter Sleight
Peter Sleight (1929–2020) was a British cardiologist, the first Field-Marshal Alexander Professor of Cardiovascular Medicine at Oxford, who chaired the ISIS trials recruiting about 140,000 patients.
Peter Tontonoz
Peter Tontonoz is an American physician-scientist and Distinguished Professor at UCLA who studies cholesterol and lipid metabolism, known for the LXR, PPAR, IDOL, and Aster protein discoveries.
Peter W.F. Wilson
Peter W.F. Wilson is an American cardiologist and cardiovascular epidemiologist at Emory University whose Framingham work produced the most widely validated heart disease risk prediction rule.
Peter Zimetbaum
Peter J. Zimetbaum is an American cardiac electrophysiologist who directs clinical cardiology at Beth Israel Deaconess Medical Center and is the Richard and Susan Smith Professor of Cardiology at Harvard Medical School.
Philip A. Poole‐Wilson
Philip A. Poole-Wilson (1943–2009) was a British cardiologist and British Heart Foundation professor at Imperial College London who chaired the COMET trial and helped make beta-blockers standard in heart failure.
Philip E. Cryer
Philip E. Cryer (1940–2024) was an American endocrinologist at Washington University in St. Louis whose research on glucose counterregulation led him to discover hypoglycemia-associated autonomic failure, also called Cryer Syndrome.
Philip Felig
Philip Felig was an American endocrinologist who spent fourteen years as a Yale professor of medicine, established the glucose-alanine cycle, led the Sandoz Research Institute, and died in 2020.
Philip Greenland
Philip Greenland is an American cardiologist and epidemiologist, the Harry W. Dingman Professor of Cardiology at Northwestern University, known for coronary artery calcium scoring for heart disease risk prediction.
Philip H. Henneman
Philip H. Henneman was an American endocrinologist who researched kidney stones and metabolic bone disease, best known for establishing urinary hydroxyproline as a marker of bone collagen turnover in 1963.
Philip J. Barter
Philip J. Barter was an Australian cardiovascular researcher specializing in HDL cholesterol and CETP, who chaired the ILLUMINATE trial of torcetrapib and won the Anitschkow Prize in 2011.
Philip Mease
Philip J. Mease is an American rheumatologist, clinical professor at the University of Washington and director of rheumatology research at Swedish Medical Center in Seattle.
Philip Needleman
Philip Needleman (1939–2024) was an American pharmacologist who chaired pharmacology at Washington University, discovered COX-2, and led Monsanto and Pharmacia research that produced the arthritis drug Celebrex.
Philip Raskin
Philip Raskin (1940–2026) was an American endocrinologist and diabetes researcher who spent 53 years at UT Southwestern Medical Center in Dallas, leading NIH trials including DCCT/EDIC, GRADE, and D2d.
Philip W. Shaul
Philip W. Shaul is an American physician-scientist in vascular biology who directs the Center for Pulmonary and Vascular Biology at UT Southwestern Medical Center in Dallas.
Philipp E. Scherer
Philipp E. Scherer is a Swiss-born cell biologist who discovered the fat-cell hormone adiponectin in 1995 and directs the Touchstone Diabetes Center at UT Southwestern in Dallas.
Philippe Coumel
Philippe Coumel (1935–2004) was a French cardiologist and clinical electrophysiologist who spent his career at Hôpital Lariboisière in Paris, introducing programmed electrical stimulation, the triangle of arrhythmogenesis, and Coumel's law.
Philippe Gabríel Steg
Philippe Gabriel Steg, also published as P. Gabriel Steg, is a French interventional cardiologist and clinical trialist who is chief of cardiology at Hôpital Bichat in Paris.
Philippe Généreux
Philippe Généreux is a Canadian interventional cardiologist at Morristown Medical Center, New Jersey, whose EARLY TAVR trial showed early valve replacement halves risk in asymptomatic aortic stenosis.
Philippe Pîbarot
Philippe Pibarot is a Canadian cardiovascular researcher, professor at Université Laval, and Canada Research Chair in Cardiac Valvular Diseases, known for work on aortic stenosis and prosthetic heart valves.
Phillip Görden
Phillip Gorden (1934–2026) was an American endocrinologist at the National Institutes of Health who served as the seventh director of NIDDK from 1986 to 1999 and pioneered leptin replacement therapy for lipodystrophy.
Piero Anversa
Piero Anversa is an Italian-trained cardiologist who directed the Center for Regenerative Medicine at Harvard's Brigham and Women's Hospital and is known for his work on cardiac stem cells.
Pierre Ducimetière
Pierre Ducimetière (1942–2026) was a French cardiovascular epidemiologist at Inserm, called the father of French cardiovascular epidemiology, who led the Paris Prospective Study and published landmark coronary heart disease research.
Pierre Théroux
Pierre Théroux (1943–2023) was a Canadian cardiologist at the Montreal Heart Institute and Université de Montréal professor whose trials defined aspirin and heparin use in acute coronary syndromes.
Pierre-François Bougnères
Pierre-François Bougnères is a French pediatric endocrinologist and Inserm research director at Paris hospitals, known for New England Journal of Medicine trials in type 1 diabetes and adrenoleukodystrophy.
Pieter C. Smits
Pieter C. Smits is a Dutch interventional cardiologist, Director of Interventional Cardiology at Maasstad Hospital in Rotterdam, and lead investigator of the COMPARE and MASTER DAPT stent trials.
Pim J. de Feyter
Pim J. de Feyter is a Dutch cardiologist and emeritus professor at Erasmus MC, Rotterdam, known for emergency angioplasty in unstable angina and for advancing coronary CT angiography.